What we're reading, May 18, 2016: Senate and House Zika funding is mismatched while CDC shifts funding from local departments for Zika, and the uninsured rate in the United States fell to 9.1% in 2015.
The Senate may have easily passed the $1.1 billion Zika funding compromise, but it is less money than the president requested. In addition, the funding is in contrast with a plan from House Republicans that reallocates just $622 million from other programs, reported The New York Times.
Meanwhile, the CDC reported it is short on funding to combat the virus and as such has shifted $44 million from local health departments to Zika preparation, according to USA Today. The CDC tapped into the Public Health Emergency Preparedness program, which helps communities deal with emergencies ranging from hurricanes to flu pandemics. Ironically, a survey of local health staff found that 60% believe the cuts will harm their ability to prepare and respond to Zika.
The uninsured rate in the United States fell below 10% for the first time in 2015. However, while the Obama administration is celebrating the figures as proof of the Affordable Care Act (ACA)’s success, critics view the success as not enough for the amount of work and money needed, reported The Wall Street Journal. In 2015, just 28.6 million Americans (9.1%) did not have insurance, which is down from 16% in 2010, the year the ACA was enacted and 11.5% in 2014, the year in which major provisions kicked in. According to estimates, the largest share of people remaining uninsured are those who could get coverage under the ACA, but are choosing not to.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More